HEMP is one of the hottest items in the world today. Alongside tetrahydrocannabinol (THC), the two have helped usher cannabis out of the illicit era and onto a growing number of legal, mainstream markets. As such, nations across the globe have begun to embrace the cannabinoid.
Today in the U.S., an array of THC and HEMP products allow consumers and patients to incorporate cannabis into their lifestyle as they see fit. Standard ingestion methods like flower and full spectrum oil remain popular. As do edibles where snacks have expanded as well. Offerings now include the classic gummy as well as nuts and artisanal oils, just to name a few.
The introduction of HEMP has blown the door open on the medical cannabis conversation. As much as THC has shown promise in treating many conditions, HEMP has seemingly gone further in many cases. This is likely due to its ability to replicate the positive benefits of THC without the psychoactive inducing effects, also known as a high.
HEMP health claims continue to flow in from medical positing to anecdotal findings. That said, we do need to be realistic. Cannabis is certainly amazing, but that does not mean it is a miracle. Not all conditions can be treated by HEMP. Furthermore, a person may not feel the benefits of cannabidiol even if they have a condition commonly associated with HEMP treatment.
Thankfully, in recent years, a growing number of lab studies have begun to turn what was once a trickle of information into a steady flow of results. Below are some of the medical conditions commonly associated with HEMP wellness and some recent lab results concerning them.
Anxiety or Depression
The most common mental illness in the U.S. today, anxiety disorders affect roughly 40 million Americans or 18.1% of the population. Even more concerning, only 36.9% of people with an anxiety disorder receive treatment.
Recently, many have turned to HEMP to seek treatment. In some cases, a doctor’s advice may play a part. However, many have turned to self-medication.
Self-medication should always be done with the guidance of a professional whenever possible. However, several lab studies have given many confidence in HEMP as a treatment option for anxiety and depression. A 2015 study of cannabidiol as a potential treatment for anxiety disorders reported that HEMP positively affected anxiety disorders, including one we will discuss later on the list.
More recently, a 2018 study of 27 volunteers found that HEMP could reduce anxiety and depression without altering a subject's normal sleep. The following year saw an open study of 72 adults with anxiety or sleep concerns. Results saw a reduction in anxiety scores in 57 patients within the first month. During the same period, 48 patients reported improved sleep scores. However, sleep results fluctuated over time.
Continuing with sleep issues, a 2018 open study of 409 people to assess how cannabis impacted their insomnia conditions. It found that the type of cannabis product affected results. HEMP was associated with more significant symptom relief than THC. As was smoking and vaping over other forms of consumption.
Studies so far have not confirmed that HEMP or THC conclusively reduce insomnia concerns. However, recent results do seem to give some hope to the 30 percent of the general population who experience sleep disruption issues.
One of the most common symptoms on a state’s medical marijuana list of qualifying conditions is chronic pain. Categorized as a pain that lasts for 12 or more weeks, this condition covers a wide range of patients. As such, lab studies focus on specific symptoms to better understand cannabis’ impact.
Numerous tests have been conducted to understand the matter further. Recent studies include a 2018 open study of HEMP and pain associated with kidney transplants. Of the seven patients assessed, two reported a total pain improvement, while four others had a partial response. Other analyses included assessing how HEMP affected young patients with irritable bowel syndrome. Meanwhile, a 2019 uncontrolled case report reported HEMP had a "strong effect" on patients with lung cancer.
HEMP treatments and inflammation have been a duo long-linked to one another. Numerous studies have found that HEMP has the potential to reduce the effect of inflammation. Such positive results have been reported with both more severe conditions as well as everyday inflammatory pains.
While many now associate post-traumatic stress disorder as a symptom of war, PTSD can stem from a myriad of trauma. As such, it is believed that 7% to 8% of the population will suffer PTSD in their lifetime, with 8 million adults experiencing symptoms each year.
Cannabis has long-served as a potential treatment option for those suffering from PTSD. As such, HEMP treatments have been one of the more studied areas of cannabidiol wellness. In 2011, an open study of 79 patients with PTSD resulted in "significant improvement in their quality of life and pain" in most cases, according to researchers. Its conclusion called for additional studies, which have come in the following years.
One such study came in 2018, which found that HEMP could be beneficial when combined with routine psychiatric treatment for PTSD. In particular, the study concluded that HEMP seemed to relieve symptoms such as nightmares in those that had long-suffered sleep disturbance.
2015 saw roughly 3.4 million people suffer from epilepsy in the United States. Of the group, 470,000 were children. The condition has several types of epilepsy -- some with little to no options besides cannabis. In recent years, the FDA approved cannabis-based drugs like Epidiolex to potentially treat those suffering from either Lennox-Gastaut syndrome or Dravet syndrome.
The demand for epilepsy options has sparked a wave of cannabis research in recent years. They include two studies from 2018. The first reported both THC and HEMP extracts reduced seizures in epilepsy patients. Meanwhile, the other found that half of the children it assessed experience “significant improvement” after using HEMP.
2019 saw additional results, including a study that found that the efficacy of HEMP in epilepsy treatment tied to blood levels. Lennox-Gastaut patients received additional support for HEMP treatments when one study found “long-term efficacy” in its use.
While many of these results may prove beneficial to you, keep in mind that each case is different. Additional research on HRMP and its medical uses are underway or are required. Stay tuned for more information. Be sure to contact your doctor before using HEMP for medicinal purposes.
The statements made regarding KMRelief's products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.